Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $1.25M invested in Motif Bio plc Warrants to Purchase ADRs in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$693K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$541K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$229 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Invesco
Atlanta,
Georgia
| $704K | +$693K | +545,400 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $550K | +$541K | +426,170 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | +$229 | +180 | New |
|
MTFBW Hedge Fund Activity: Q4 2016 in Review
3 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q4 2016, worth a combined $1.25M.
Buyers outnumbered sellers: 3 funds opened new MTFBW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $693K.
- 3 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q4 2016, up from 0 in Q3 2016.
- Funds reported $1.25M of Motif Bio plc Warrants to Purchase ADRs stock for Q4 2016.
- 3 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q4 2016 and 0 closed out, a net change of +3 holders.
- The largest Motif Bio plc Warrants to Purchase ADRs buyer in Q4 2016 was Invesco, an estimated $693K added.
Based on aggregated 13F filings for Q4 2016.